BIRC5 and cervical carcinoma: The pooled HR was 1.129 (95% CI: 0.597–1.661; P = 0.000), indicating that survivin expression was significantly associated with poor survival in cervical carcinoma compared to cancer tissues exhibiting no expression of survivin.